By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Breckenridge Pharmaceutical, Inc. 

1141 S. Rogers Circle
Suite 3
Boca Raton  Florida  33487  U.S.A.
Phone: 800-367-3395 Fax: 561-989-9747


SEARCH JOBS


Industry
Pharmaceutical






Company News
Breckenridge Pharmaceutical, Inc. Announces Approval For Azelastine HCl Nasal Solution (Nasal Spray) 7/29/2015 11:48:30 AM
Breckenridge Pharmaceutical, Inc. Announces Final ANDA Approval For Desvenlafaxine XR Tablets (Pristiq) 7/2/2015 6:11:31 AM
Breckenridge Pharmaceutical, Inc. Announces Approval for Repaglinide Tablets, USP 4/29/2015 9:52:55 AM
Breckenridge Pharmaceutical, Inc. Announces Paragraph IV ANDA Litigation With Boehringer Ingelheim For Its ANDA Dabigatran Etexilate Mesylate Capsules (Pradaxa) 3/13/2015 6:56:27 AM
Breckenridge Pharmaceutical, Inc. Announces Paragraph IV ANDA Litigation With Sanofi (SAN.PA) For Its ANDA Cabazitaxel Solution; IV (Infusion) (Jevtana) 2/12/2015 6:42:30 AM
Breckenridge Pharmaceutical, Inc. Signs Multi-Product Generic Agreement With MSN Laboratories Pvt. Ltd. 12/22/2014 7:34:55 AM
Breckenridge Pharmaceutical, Inc. Signs Multi-Product Generic Agreement With Pharmaceutics International, Inc. 11/25/2014 1:55:13 PM
Breckenridge Pharmaceutical, Inc. Announces Appointment of New President 11/20/2014 12:38:26 PM
Breckenridge Pharmaceutical, Inc. Announces Approval Of QUETIAPINE FUMARATE TABLETS 11/3/2014 9:28:13 AM
Breckenridge Pharmaceutical, Inc. Announces Approval of Mefenamic Acid Capsules, USP 250mg 10/14/2014 8:59:59 AM
12345
//-->